Resilience Enhancement Using Electronic Frailty Index-Directed Care Pathway

Recruiting N/A Interventional Study
Cancer Frail Chemotherapy
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
65 and older
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
32 (estimated)
Sponsor
Wake Forest University Health Sciences · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The study purpose is to gain a better understanding of the needs of adults aged 65 and older while they are receiving chemotherapy by measuring their resilience and tailor care plans based on their individual needs.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Patients with cancer: * Ability to understand and willingness to sign an IRB-approved informed consent * Age ≥ 65 years at the time of enrollment. * Planned to initiate an outpatient chemotherapy regimen (including myelosuppressive biologic/immune therapies) for cancer treatmen…
Contacts

James Morgan

336-702-4491

james.morgan@advocatehealth.org

CONTACT